Recent progress in cancer treatment continue to provide promise for patients. Researchers are intensely exploring novel approaches, including immunotherapy , targeted agents, and individualized approaches. A key study published this week highlights the efficacy of a new drug in managing late-stage NSCLC. Furthermore, continued investigations are ce